← FDA DRUG APPROVALS

FDA ANDA · ANDA083347

QUINIDINE SULFATE

Sponsor: IMPAX LABS

APPLICATION
ANDA083347
TYPE
ANDA
ORIGINAL APPROVAL
1976-12-08
LATEST ACTION
2001-02-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

QUINIDINE SULFATEDiscontinued
QUINIDINE SULFATE 200MG · TABLET · ORAL

Approval history

2001-02-21Labeling · Supplement 26AP
1990-02-28Labeling · Supplement 30AP
1990-02-28Labeling · Supplement 29AP
1988-12-23Labeling · Supplement 28AP
1988-11-23Labeling · Supplement 27AP
1976-12-08OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →